This site is intended for healthcare professionals only
LoginRegister
Granules Indias US Arm Gets 4 USFDA ObservationsGranules India's US Packaging Facility Secures USFDA EIR with Zero Observations
Indian Pharma Faces Rs 5,000 Crore Export Risk as Middle East Conflict Drives Freight Charges UpIndian Pharma Faces Rs 5,000 Crore Export Risk as Middle East Conflict Drives Freight Charges Up
USFDA Approves Johnson and Johnson Blood Cancer Drug Tecvayli-Darzalex ComboUSFDA Approves Johnson and Johnson's Blood Cancer Drug Tecvayli-Darzalex Combo via Fast-Track...
Global Fund expands commitment to improve access to HIV drugSouth Africa Pushes for Local Manufacturing of Gilead's HIV Drug Lenacapavir to Boost Access
Aurobindo Arm CuraTeQ Partners STADA Arzneimittel AG to Commercialise Biosimilars in EuropeAurobindo Subsidiary Eugia Launches Generic Pomalyst Capsules in US
Sanofis Sarclisa Gets EMA Nod for Subcutaneous On-Body Injector VersionSanofi's Diabetes Drug Lantus SoloStar Insulin Batch Stolen, CDSCO Issues Alert
Pharma Firm Blacklisted in Goa Over Alleged Spurious Anti-Snake Venom SupplyPharma Firm Blacklisted in Goa Over Alleged Spurious Anti-Snake Venom Supply
Natco PharmaNatco Pharma Enters USD 3.2 Billion US Pomalidomide Market, Claims 180-Day Exclusivity
Caplin Steriles Secures USFDA Nod for Generic DEPO-MEDROL InjectionCaplin Steriles Secures USFDA Nod for Generic DEPO-MEDROL Injection
Traveres Filspari Becomes First USFDA-Approved Drug for FSGS TreatmentUSFDA Operations Chief Barclay Butler to Retire, Veteran Melanie Keller to Take Charge
Semaglutide Misuse Under Watch: Telangana DCA Issues Advisory After Generic Launch SurgeIndia's Semaglutide Market Set for Generic Boom as Patents Expire, Over 50 Brands Lined Up for...
Emcure to Market Roches CellCept, Mircera, Neorecormon Under New India PactEmcure to Market Roche's CellCept, Mircera, Neorecormon Under New India Pact
X